NEW ORLEANS — Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with ...

June 6 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not ...

Please provide your email address to receive an email when new articles are posted on . CGM improved HbA1c, time in range and other metrics over 26 weeks. CONNECT trial suggests CGM can be considered ...

Overall, 18,556 women developed diabetes during follow-up — 20.1% with prior gestational diabetes vs 2.0% without. Of these, 655 (3.5%) developed diabetic retinopathy, and 38.1% developed hypertension ...

What Is Afrezza, and Why Does It Matter? Afrezza is a fast-acting insulin that you breathe in as you start a meal. It lowers blood sugar by helping your muscles and fat use sugar and by telling your ...

When a clinician prescribes a medication for a purpose for which it’s not indicated by the U.S. Food and Drug Administration (FDA), it’s referred to as off-label treatment. Doctors may recommend ...

Claude Projects provides a structured way to manage work by creating dedicated AI-powered workspaces that centralize files, instructions and conversations. In his guide, Kevin Stratvert walks through ...

Smoking, vaping, or using both products significantly increases the likelihood of developing prediabetes and diabetes, and the risk is even higher among Hispanic, Black, and low-income groups.

Iran's regime already claimed on Monday to have hit a U.S. warship with missiles. U.S. Central Command announced Sunday that the newest military strategy to reopen the Strait of Hormuz to broader ...

In “Project Maven,” Katrina Manson shows us how close we are to artificial intelligence picking targets and dropping bombs without human input. By Fred Kaplan Fred Kaplan, Slate’s War Stories ...

The American College of Lifestyle Medicine (ACLM) announces the launch of Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes, a national digital film series developed in partnership ...